¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"antigens, surface"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • quadratic surface
    ÀÌÂ÷°î¸é
  • root surface cavity
    Ä¡¾Æ»Ñ¸®¸é°ø°£
  • source-surface distance
    ¿øÃµÇ¥¸é»çÀ̰Ÿ®, ¿øÃµÇ¥¸é°£°Å¸®
  • surface
    1. Ç¥¸é 2. ¸é
  • surface anesthesia
    Ç¥¸é¸¶Ãë
  • surface antigen
    Ç¥¸éÇ׿ø
  • surface area
    Ç¥¸éÀû
  • surface caries
    Ç¥¸é¿ì½Ä
  • surface catalysis
    Ç¥¸éÃ˸ÅÀÛ¿ë
  • surface characteristic
    Ç¥¸éƯ¼º
  • surface chemistry
    Ç¥¸éÈ­ÇÐ
  • surface coil
    Ç¥¸éÄÚÀÏ, Ç¥¸é°ËÃâ±â
  • surface coupling
    Ç¥¸é°áÇÕ
  • surface electrode
    Ç¥¸éÀü±Ø
  • surface fixation
    Ç¥¸é°íÁ¤
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • surface characteristic
    Ç¥¸éƯ¼º
  • surface chemistry
    °è¸éÈ­ÇÐ
  • surface coil
    Ç¥¸éÄÚÀÏ, Ç¥¸é°ËÃâ±â
  • surface cooling
    Ç¥¸é³Ã°¢
  • surface coupling
    Ç¥¸é°áÇÕ
  • depth resolved surface coil spectroscopy
    ±íÀÌÇØ°áÇ¥¸éÄÚÀϺб¤¹ý
  • dorsal surface
    µîÂʸé, µÚ¸é
  • source-surface distance
    ¼±¿øÇ¥¸é°£°Å¸®
  • surface tension depressant
    Ç¥¸éÀå·ÂÀúÇÏÁ¦
  • surface-active disinfectant
    Ç¥¸éȰ¼º¼Òµ¶Á¦, °è¸éȰ¼º¼Òµ¶Á¦
  • exposed surface
    ³ëÃâ¸é
  • external surface
    ¹Ù±ù¸é
  • extraplasmic surface
    ÇüÁú¸·¹Ù±ù¸é
  • surface electrode
    Ç¥¸éÀü±Ø
  • fetal surface
    žÆÇ¥¸é
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anterior surface
    ¾Õ¸é
  • anterior surface of eyelid
    ´«²¨Ç®¾Õ¸é
  • anterior surface of petrous portion
    ¹ÙÀ§¾Õ¸é
  • anterolateral surface
    ¾Õ°¡Âʸé
  • anteromedial surface
    ¾Õ¾ÈÂʸé
  • antigen, hepatitis B surface
    BÇü °£¿°¹ÙÀÌ·¯½º Ç¥¸éÇ׿ø
  • approximal surface
    Á¢Ã˸é
  • articular surface
    °üÀý ¸é(¡­Øü).
  • articular surface
    °üÀý¸é
  • articular surface for cuboid bone
    ÀÔ¹æ°üÀý¸é
  • articular surface for fibula
    Á¾¾Æ¸®°üÀý¸é
  • articular surface for navicular bone
    ¹ß¹è°üÀý¸é
  • articular surface of fibular head
    Á¾¾Æ¸®»À¸Ó¸®°üÀý¸é
  • articular surface of head of rib
    °¥ºñ»À¸Ó¸®°üÀý¸é
  • articular surface of tubercle
    °¥ºñ»À°áÀý°üÀý¸é
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anteromedial surface
    ¾Õ¾ÈÂʸé
  • antigen, hepatitis B surface
    BÇü °£¿°¹ÙÀÌ·¯½º Ç¥¸éÇ׿ø
  • approximal surface
    Á¢Ã˸é
  • articular surface
    °üÀý ¸é(¡­Øü).
  • articular surface
    °üÀý¸é
  • articular surface for cuboid bone
    ÀÔ¹æ°üÀý¸é
  • articular surface for fibula
    Á¾¾Æ¸®°üÀý¸é
  • articular surface for navicular bone
    ¹ß¹è°üÀý¸é
  • articular surface of fibular head
    Á¾¾Æ¸®»À¸Ó¸®°üÀý¸é
  • articular surface of head of rib
    °¥ºñ»À¸Ó¸®°üÀý¸é
  • articular surface of tubercle
    °¥ºñ»À°áÀý°üÀý¸é
  • arytenoid articular surface
    ¸ð»Ô°üÀý¸é
  • auricular surface
    ±Í¸ð¾ç¸é
  • body surface
    üǥ(¸é)(ô÷øúØü)
  • body surface area
    üǥ¸éÀû
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Viceral surface
    ³»Àå¸é
    [¿¾ ¿ë¾î] ÀåÃø¸é
  • Visceral surface
    ³»Àå¸é
    [¿¾ ¿ë¾î] ÀåÃø¸é
  • Posterior surface of eyelids
    ´«²¨Ç®µÚ¸é
    [¿¾ ¿ë¾î] ¾È°ËÈĸé
  • Anterior surface of eyelid
    ´«²¨Ç®¾Õ¸é
    [¿¾ ¿ë¾î] ¾È°ËÀü¸é
  • Orbital surface
    ´«È®¸é
    [¿¾ ¿ë¾î] ¾È¿Í¸é
  • Cerebral surface
    ´ë³ú¸é
    [¿¾ ¿ë¾î] ´ë³ú¸é
  • Symphyseal surface
    µÎµ¢°áÇÕ¸é
    [¿¾ ¿ë¾î] Ä¡°ñ°áÇÕ¸é
  • Posterior articular surface
    µÚ°üÀý¸é
    [¿¾ ¿ë¾î] ÈİüÀý¸é
  • Dorsal surface
    µÚ¸é
    [¿¾ ¿ë¾î] Èĸé
  • Intestinal surface
    µÚ¸é
    [¿¾ ¿ë¾î] Èĸé
  • Posterior surface
    µÚ¸é
    [¿¾ ¿ë¾î] Èĸé
  • Posterior articular surface for talus
    µÚ¸ñ¸»°üÀý¸é
    [¿¾ ¿ë¾î] ÈİŰñ°üÀý¸é
  • Posterior calcaneal articular surface
    µÚ¹ß²ÞÄ¡°üÀý¸é
    [¿¾ ¿ë¾î] ÈÄÁ¾°ñ°üÀý¸é
  • Dorsal surface
    µî¸é
    [¿¾ ¿ë¾î] ¹èÃø¸é
  • Dorsal surface
    µîÂʸé
    [¿¾ ¿ë¾î] ¹èÃø¸é
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • surface membrane proteins
    Ç¥¸é¸·´Ü¹éÁú (øúØüدӱÛÜòõ)
  • surface potential
    Ç¥¸éÀüÀ§ (øúØüï³êÈ)
  • surface pressure
    Ç¥¸é¾Ð (øúØüäâ)
  • surface tension
    Ç¥¸éÀå·Â (øúØüíåÕô)
  • van der Waals surface
    ¹Ý µ§ ¹ß½º Ç¥¸é (øúØü)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • wound surface
    â¸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
ESA Electrolysis Society of America; endocardial surface area; epidermal surface antigen; esterase; este...
SA salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame...
SSD shaded surface display; single saturating dose; Social Security disability; source-skin distance; so...
¥áHBs Antibody against Hepatitis B surface Antigen
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MAIPA Monoclonal Antibody-specific Immobilisation of Platelet Antigens
BSA A/body surface area
ASL Airway surface liquid
anti HBs Antibody to hepatitis B surface antigen
BSPM body surface potential map
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • equipotential surface
    µîÀüÀ§ ¸é
  • exposed surface
    ³ëÃâ¸é
  • fatty coating of surface
    Ç¥¸éÀÌ Áö¹æÀ¸·Î µ¤Çô ÀÖ´Â
  • flexor surface
    ±¼°î¸é, ±¼±Ù¸é
  • free surface
    ÀÚÀ¯ ¸é
  • high surface
    °íÇ¥¸é
  • impression of root surface
    ±Ù¸é Àλó
  • impression surface
    Àλó¸é
    ±¸°­ Á¶Á÷ÀÇ ÀÎ»ó¿¡ ÀÇÇØ¼­ °áÁ¤µÈ ÀÇÄ¡ÀÇ Ç¥¸é.
  • inferior surface
    ¾Æ·¡ ¸é
  • inferior surface of tongue
    Çô ¾Æ·¡ ¸é
  • interfacial surface tension
    ÀÇÄ¡ Ç¥¸é Àå·Â
    ÀÇÄ¡ÀÇ Á¢ÇÕµµ°¡ ÁÁÀº °æ¿ì¿¡ À־ ÀÇÄ¡»ó°ú Á¶Á÷°úÀÇ »çÀÌ¿¡ ¾×ü°¡ ¾ãÀº ¸·À¸·Î Çü¼ºµÇ¾î ÀÇÄ¡ÀÇ Å»¶ôÀ» ¹æÁöÇÑ ÀúÇ×·ÂÀÌ´Ù.
  • jugular surface
    °æÁ¤¸Æ Ç¥¸é
  • keratotic surface
    °¢Áú Ç¥¸é
  • labial surface
    ¼ø¸é, ÀüÁ¤¸é
    1. ÀÔ¼ú ÂÊÀ¸·Î ÇâÇÑ ¸é. 2. Ä¡¾ÆÀÇ ÀÔ¼úÃø ¸é.
  • large surface form
    ³ÐÀº ¸éÀÇ ÇüÅÂ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
antigens, CD20 <immunology> Unglycosylated phosphoproteins expressed only on B-cells. They are regulators of transmembrane calcium conductance and thought to play a role in B-cell activation and proliferation.
(12 Dec 1998)
antigens, CD26 <enzyme, immunology> Cell-surface glycoproteins and serine protease, also known as dipeptidyl-peptidase IV, that play a role in t-lymphocyte activation. Cd26 binds to adenosine deaminase on the T-cell surface.
Registry number: EC 3.4.14.5
(12 Dec 1998)
antigens, CD27 <immunology> Dimeric membrane glycoproteins found on most T-lymphocytes. Activation of T-cells by the antigen receptor increases CD27 surface expression.
(12 Dec 1998)
antigens, CD28 <immunology> T-cell differentiation antigens that serve as the receptors for the b7 antigen (antigens, CD80) which modulates T-cell lymphokine production.
(12 Dec 1998)
antigens, CD29 <immunology> Integrin beta-1 chains which are expresssed as heterodimers noncovalently associated with specific alpha-chains of the CD49 family (CD49a-f). Cd29 is expressed on resting and activated leukocytes and is a marker for total very late activation antigens on cells. (barclay et al., the leukocyte antigen factsbook, 1993, p164)
(12 Dec 1998)
antigens, CD3 <immunology> A complex of at least five membrane-bound polypeptides in mature T-lymphocytes that are non-covalently associated with one another and with the T-cell receptor (receptors, antigen, T-cell). The CD3 complex includes the gamma, delta, epsilon, zeta, and eta chains (subunits). When antigen binds to the T-cell receptor, the CD3 complex transduces the activating signals to the cytoplasm of the T-cell. The CD3 gamma and delta chains (subunits) are separate from and not related to the gamma/delta chains of the T-cell receptor (receptors, antigen, T-cell, gamma-delta).
(12 Dec 1998)
antigens, CD30 <immunology> Differentiation antigens normally present in a small number of cells in the lymph nodes and tonsils in vivo, but also capable of being induced in a wide range of cells in vitro. They are clinically useful as tumour markers for ki-1 lymphoma (lymphoma, large-cell, ki-1) and some cases of lymphomatoid papulosis, mycosis fungoides, and hodgkin's disease.
(12 Dec 1998)
antigens, CD31 <immunology> Cell adhesion molecules present on virtually all monocytes, platelets, and granulocytes. Cd31 is highly expressed on endothelial cells and concentrated at the junctions between them.
(12 Dec 1998)
antigens, CD34 <immunology> Glycoproteins found on immature haematopoietic cells and endothelial cells. They are the only molecules to date whose expression within the blood system is restricted to a small number of progenitor cells in the bone marrow.
(12 Dec 1998)
antigens, CD36 <immunology> Leukocyte differentiation antigens and major platelet membrane glycoproteins present on monocytes, endothelial cells, platelets, mammary epithelial cells, and a variety of cultured cell lines. They play major roles in adhesion phenomena, signal transduction, and haematopathology. Cd36 is also the receptor for thrombospondin and malaria-infected erythrocytes.
(12 Dec 1998)
antigens, CD4 <immunology> 55-kD glycoproteins originally defined as differentiation antigens on T-lymphocytes, but also found on other cells including monocytes/macrophages. CD4 antigens are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MHC (major histocompatibility complex) class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. Cd4 antigens also serve as HIV receptors, binding directly to the envelope protein gp120 on HIV.
The protein structure on the surface of a human cell that allows HIV to attach, enter, and thus infect a cell. CD4 receptors are present on CD4 cells (helper T-cells), macrophages and dendritic cells, among others. Normally, CD4 acts as an accessory molecule, forming part of larger structures (such as the T-cell receptor) through which Tcells and other cells signal each other.
(12 Dec 1998)
antigens, CD40 <immunology> Differentiation antigens found on all mature B-lymphocytes and some epithelial cells, carcinomas, and lymphoid dendritic cells. This is a member of the tumour necrosis factor superfamily. Evidence suggests that CD40-dependent activation of B-cells is important for generation of memory B-cells within the germinal centres.
(12 Dec 1998)
antigens, CD44 <immunology> Acidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary thymocytes, granulocytes, macrophages, erythrocytes, and fibroblasts. Cd44 antigens are the principle cell surface receptors for hyaluronate and this interaction mediates binding of lymphocytes to high endothelial venules.
(12 Dec 1998)
antigens, CD45 <immunology> High-molecular weight glycoproteins uniquely expressed on the surface of all leukocytes and their haemopoietic progenitors. The CD45 family consists of multiple members that are all products of a single gene. Cd45 expression is necessary for signalling through the T-cell receptor.
(12 Dec 1998)
antigens, CD5 <immunology> Glycoproteins expressed on all mature T-cells, thymocytes, and a subset of mature B-cells. Antibodies specific for CD5 can enhance T-cell receptor-mediated T-cell activation. The B-cell-specific molecule CD72 is a natural ligand for CD5.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á